Co-expression of <i>PKCζ</i> and <i>ALDH1A3</i> Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer.

Cancer Genomics Proteomics · 2026 · PMC12951394 · PMID 41771575

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Similarly, no significant prognostic differences were observed in patients treated with taxane-based regimens; however, PKCζ high expression consistently showed a trend toward poorer outcomes.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Co-expression of &lt;i&gt;PKCζ&lt;/i&gt; and &lt;i&gt;ALDH1A3&lt;/i&gt; Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer.

The sentences

Co-expression of <i>PKCζ</i> and <i>ALDH1A3</i> Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer.